New NHS Weight Loss Treatment – Tirzepatide (Mounjaro)

Posted by: monifap - Posted on:


Some GP practices can begin offering a new NHS treatment called Tirzepatide (Mounjaro).

Tirzepatide (Mounjaro) is to help people with obesity lose weight and help with weight related health problems.

This does not mean the medicine will be prescribed straight away or available immediately. This treatment is also only available to people who have certain medical conditions.

We are experiencing a lot of enquiries about this. Please be patient with us while the NHS rolls out this treatment safely and fairly.

You can find lots of useful information about Tirzepatide (Mounjaro) here ICB advice and support weight loss drugs information for patients. This includes details about who is eligible and other options to support you with weight loss.

If you need advice about your weight, you can book a routine appointment with a GP or healthcare professional to talk about your options. This may include whether Tirzepatide (Mounjaro) is suitable for you.

Who can get this treatment?

Tirzepatide will only be offered to people who have the highest clinical need, this means those whose health is most affected by obesity and who are likely to benefit the most.

To be considered for this treatment, you must:

  • Have a Body Mass Index (BMI) of 40 or more, and
  • Have at least four of the following health conditions:
    • High blood pressure
    • High cholesterol or high fat levels in the blood
    • Sleep apnoea (trouble breathing while asleep)
    • Heart disease
    • Type 2 diabetes

Important things to know

  • You will need a full clinical assessment.
  • Tirzepatide (Mounjaro) will only be given as part of a full NHS care plan. This includes referral to wrap around care programme to support with healthy eating and lifestyle changes.
  • Other NHS weight management services are still available and may be more suitable for you.

You can read more in the official NHS weight loss treatment guidance.

Please do not call NHS North East and North Cumbria Integrated Care Board (ICB) about this medicine – they are not able to give any further information.

The number of patients who fall in this category are very minimal and the majority of patients do not qualify for these injections based on these criteria. 

We are in the process of identifying our cohort of patients who do fall within the criteria. We have been inundated with significant number of calls enquiring about weight loss injections and may we kindly request you to bear with us till we contact you if you are eligible.